Value Set ELGA_whoATC 2013‑01‑10

Diese Terminologie ist eine Momentaufnahme vom 2023‑05‑08 14:49:15. Terminologien können sich im Laufe der Zeit weiterentwickeln. Wenn eine neuere (dynamische) Versionen dieser Terminologie benötigt wird, bitte von der Quelle abrufen.

1.2.40.0.34.10.73

Gültigkeit

2013‑01‑10

Status

Definitiv

Versions-Label

Name

ELGA_whoATC

Bezeichnung

ELGA_whoATC

Beschreibung

ELGA Valueset für ATC

Quell-Codesystem

2.16.840.1.113883.6.73 - WHO Anatomical Therapeutic Chemical classification - FHIR: http://www.whocc.no/atc - HL7 V2: WC

Level/ Typ	Code	Bezeichnung	Codesystem
0‑L	A	Alimentäres System und Stoffwechsel	WHO Anatomical Therapeutic Chemical classification
0‑L	A01	Stomatologika	WHO Anatomical Therapeutic Chemical classification
0‑L	A01a	Stomatologika	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AA	Mittel zur Kariesprophylaxe	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AA01	Natriumfluorid	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AA02	Natriummonofluorphosphat	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AA03	Olaflur	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AA04	Zinn(II)-fluorid	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AA30	Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AA51	Natriumfluorid, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB	Antiinfektiva und Antiseptika zur oralen Lokalbehandlung	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB02	Wasserstoffperoxid	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB03	Chlorhexidin	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB04	Amphotericin B	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB05	Polynoxylin	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB06	Domiphen	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB07	Oxychinolin	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB08	Neomycin	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB09	Miconazol	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB10	Natamycin	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB11	Verschiedene	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB12	Hexetidin	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB13	Tetracyclin	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB14	Benzoxoniumchlorid	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB15	Tibezoniumiodid	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB16	Mepartricin	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB17	Metronidazol	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB18	Clotrimazol	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB19	Natriumperborat	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB21	Chlortetracyclin	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB22	Doxycyclin	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB23	Minocyclin	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AC	Corticosteroide zur oralen Lokalbehandlung	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AC01	Triamcinolon	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AC02	Dexamethason	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AC03	Hydrocortison	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AC54	Prednisolon, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AD	Andere Mittel zur oralen Lokalbehandlung	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AD01	Epinephrin	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AD02	Benzydamin	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AD05	Acetylsalicylsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AD06	Adrenalon	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AD07	Amlexanox	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AD11	Verschiedene	WHO Anatomical Therapeutic Chemical classification
0‑L	A02	Mittel bei säure bedingten Erkrankungen	WHO Anatomical Therapeutic Chemical classification
0‑L	A02A	Antacida	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AA	Magnesium-haltige Verbindungen	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AA01	Magnesiumcarbonat	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AA02	Magnesiumoxid	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AA03	Magnesiumperoxid	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AA04	Magnesiumhydroxid	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AA05	Magnesiumsilikat	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AA10	Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AB	Aluminium-haltige Verbindungen	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AB01	Aluminiumhydroxid	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AB02	Algeldrat	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AB03	Aluminiumphosphat	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AB04	Dihydroxyalumiumnatriumcarbonat	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AB05	Aluminiumacetoacetat	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AB06	Aloglutamol	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AB07	Aluminiumglycinat	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AB10	Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AC	Calcium-haltige Verbindungen	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AC01	Calciumcarbonat	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AC02	Calciumsilikat	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AC10	Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AD	Kombinationen und Komplexe von Aluminium-, Calcium- und Magnesium-haltigen Verbindungen	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AD01	Einfache Salzkombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AD02	Magaldrat	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AD03	Almagat	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AD04	Hydrotalcit	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AD05	Almasilat	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AF	Antacida mit Karminativa	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AF01	Magaldrat und Karminativa	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AF02	Einfache Salzkombinationen und Karminativa	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AG	Antacida mit Spasmolytika	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AH	Antacida mit Natriumbicarbonat	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AX	Antacida, andere Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A02B	Mittel bei peptischem Ulkus und gastroesophagealer Refluxkrankheit	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BA	Histamin-H2-Rezeptorantagonisten	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BA01	Cimetidin	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BA02	Ranitidin	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BA03	Famotidin	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BA04	Nizatidin	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BA05	Niperotidin	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BA06	Roxatidin	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BA07	Ranitidinbismutcitrat	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BA08	Lafutidin	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BA51	Cimetidin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BA53	Famotidin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BB	Prostaglandine	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BB01	Misoprostol	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BB02	Enprostil	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BC	Protonenpumpenhemmer	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BC01	Omeprazol	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BC02	Pantoprazol	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BC03	Lansoprazol	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BC04	Rabeprazol	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BC05	Esomeprazol	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BC06	Dexlansoprazol	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BD	Kombinationen zur Eradikation von Helicobacter pylori	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BD01	Omeprazol, Amoxicillin und Metronidazol	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BD02	Lansoprazol, Tetracyclin und Metronidazol	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BD03	Lansoprazol, Amoxicillin und Metronidazol	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BD04	Pantoprazol, Amoxicillin und Clarithromycin	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BD05	Omeprazol, Amoxicillin und Clarithromycin	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BD06	Esomeprazol, Amoxicillin und Clarithromycin	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BD08	Bismutsubcitrat, Tetracyclin und Metronidazol	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX	Andere Mittel bei peptischem Ulkus und gastroesophagealer Refluxkrankheit	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX01	Carbenoxolon	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX02	Sucralfat	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX03	Pirenzepin	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX04	Methiosulfoniumchlorid	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX05	Bismutsubcitrat	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX06	Proglumid	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX07	Gefarnat	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX08	Sulglicotid	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX09	Acetoxolon	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX10	Zolimidin	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX11	Troxipid	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX12	Bismutsubnitrat	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX13	Alginsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX51	Carbenoxolon, Kombinationen exkl. Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX71	Carbenoxolon, Kombinationen mit Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX77	Gefarnat, Kombinationen mit Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	A02X	Andere Mittel bei säure bedingten Erkrankungen	WHO Anatomical Therapeutic Chemical classification
0‑L	A03	Mittel bei funktionellen gastrointestinalen Störungen	WHO Anatomical Therapeutic Chemical classification
0‑L	A03A	Mittel bei funktionellen Störungen des Darms	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AA	Synthetische Anticholinergika, Ester mit tertiären Aminogruppen	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AA01	Oxyphencyclimin	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AA03	Camylofin	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AA04	Mebeverin	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AA05	Trimebutin	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AA06	Rociverin	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AA07	Dicycloverin	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AA08	Dihexyverin	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AA09	Difemerin	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AA30	Piperidolat	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB	Synthetische Anticholinergika, quartäre Ammonium-Verbindungen	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB01	Benzilon	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB02	Glycopyrronium	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB03	Oxyphenonium	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB04	Penthienat	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB05	Propanthelin	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB06	Otiloniumbromid	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB07	Methanthelinium	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB08	Tridihexethyl	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB09	Isopropamid	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB10	Hexocyclium	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB11	Poldin	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB12	Mepenzolat	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB13	Bevonium	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB14	Pipenzolat	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB15	Diphemanil	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB16	(2-Benzhydryloxyethyl)diethylmethyl-ammoniumiodid	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB17	Tiemoniumiodid	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB18	Prifiniumbromid	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB19	Timepidiumbromid	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB21	Fenpiverinium	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB53	Oxyphenonium, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AC	Synthetische Spasmolytika, Amide mit tertiären Aminen	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AC02	Dimethylaminopropionylphenothiazin	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AC04	Nicofetamid	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AC05	Tiropramid	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AD	Papaverin und Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AD01	Papaverin	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AD02	Drotaverin	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AD30	Moxaverin	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AE	Auf Serotonin-Rezeptoren wirkende Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AE01	Alosetron	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AE02	Tegaserod	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AE03	Cilansetron	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX	Andere Mittel bei funktionellen Störungen des Darms	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX01	Fenpipran	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX02	Diisopromin	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX03	Chlorbenzoxamin	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX04	Pinaverium	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX05	Fenoverin	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX06	Idanpramin	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX07	Proxazol	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX08	Alverin	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX09	Trepibuton	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX10	Isomethepten	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX11	Caroverin	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX12	Phloroglucinol	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX13	Silikone	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX30	Trimethyldiphenylpropylamin	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX58	Alverin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A03B	BELLADONNA UND DERIVATE, REIN	WHO Anatomical Therapeutic Chemical classification
0‑L	A03BA	Belladonna-Alkaloide, tertiäre Amine	WHO Anatomical Therapeutic Chemical classification
0‑L	A03BA01	Atropin	WHO Anatomical Therapeutic Chemical classification
0‑L	A03BA03	Hyoscyamin	WHO Anatomical Therapeutic Chemical classification
0‑L	A03BA04	Belladonna-Gesamtalkaloide	WHO Anatomical Therapeutic Chemical classification
0‑L	A03BB	Belladonna-Alkaloide, halbsynthetisch, quartäre Ammonium-Verbindungen	WHO Anatomical Therapeutic Chemical classification
0‑L	A03BB01	Butylscopolamin	WHO Anatomical Therapeutic Chemical classification
0‑L	A03BB02	Methylatropin	WHO Anatomical Therapeutic Chemical classification
0‑L	A03BB03	Methylscopolamin	WHO Anatomical Therapeutic Chemical classification
0‑L	A03BB04	Fentonium	WHO Anatomical Therapeutic Chemical classification
0‑L	A03BB05	Cimetropiumbromid	WHO Anatomical Therapeutic Chemical classification
0‑L	A03C	Spasmolytika in Kombination mit Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CA	Synthetische Anticholinergika in Kombination mit Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CA01	Isopropamid und Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CA02	Clidinium und Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CA03	Oxyphencyclimin und Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CA04	Otiloniumbromid und Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CA05	Glycopyrronium und Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CA06	Bevonium und Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CA07	Ambutonium und Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CA08	Diphemanil und Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CA30	Emepronium und Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CA34	Propanthelin und Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CB	Belladonna und Derivate in Kombination mit Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CB01	Methylscopolamin und Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CB02	Belladonna-Gesamtalkaloide und Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CB03	Atropin und Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CB04	Methylhomatropin und Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CB31	Hyoscyamin und Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CC	Andere Spasmolytika in Kombination mit Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	A03D	Spasmolytika in Kombination mit Analgetika	WHO Anatomical Therapeutic Chemical classification
0‑L	A03DA	Synthetische Anticholinergika in Kombination mit Analgetika	WHO Anatomical Therapeutic Chemical classification
0‑L	A03DA01	Tropenzilon und Analgetika	WHO Anatomical Therapeutic Chemical classification
0‑L	A03DA02	Pitofenon und Analgetika	WHO Anatomical Therapeutic Chemical classification
0‑L	A03DA03	Bevonium und Analgetika	WHO Anatomical Therapeutic Chemical classification
0‑L	A03DA04	Ciclonium und Analgetika	WHO Anatomical Therapeutic Chemical classification
0‑L	A03DA05	Camylofin und Analgetika	WHO Anatomical Therapeutic Chemical classification
0‑L	A03DA06	Trospium und Analgetika	WHO Anatomical Therapeutic Chemical classification
0‑L	A03DA07	Tiemoniumiodid und Analgetika	WHO Anatomical Therapeutic Chemical classification
0‑L	A03DB	Belladonna und Derivate in Kombination mit Analgetika	WHO Anatomical Therapeutic Chemical classification
0‑L	A03DB04	Butylscopolamin und Analgetika	WHO Anatomical Therapeutic Chemical classification
0‑L	A03DC	Andere Spasmolytika in Kombination mit Analgetika	WHO Anatomical Therapeutic Chemical classification
0‑L	A03E	Spasmolytika und Anticholinergika in Kombination mit anderen Mitteln	WHO Anatomical Therapeutic Chemical classification
0‑L	A03EA	Spasmolytika, Psycholeptika und Analgetika in Kombination	WHO Anatomical Therapeutic Chemical classification
0‑L	A03ED	Spasmolytika in Kombination mit anderen Mitteln	WHO Anatomical Therapeutic Chemical classification
0‑L	A03F	Prokinetika	WHO Anatomical Therapeutic Chemical classification
0‑L	A03FA	Prokinetika	WHO Anatomical Therapeutic Chemical classification
0‑L	A03FA01	Metoclopramid	WHO Anatomical Therapeutic Chemical classification
0‑L	A03FA02	Cisaprid	WHO Anatomical Therapeutic Chemical classification
0‑L	A03FA03	Domperidon	WHO Anatomical Therapeutic Chemical classification
0‑L	A03FA04	Bromoprid	WHO Anatomical Therapeutic Chemical classification
0‑L	A03FA05	Alizaprid	WHO Anatomical Therapeutic Chemical classification
0‑L	A03FA06	Cleboprid	WHO Anatomical Therapeutic Chemical classification
0‑L	A04	Antiemetika und Mittel gegen Übelkeit	WHO Anatomical Therapeutic Chemical classification
0‑L	A04A	Antiemetika und Mittel gegen Übelkeit	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AA	Serotonin-5HT3-Antagonisten	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AA01	Ondansetron	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AA02	Granisetron	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AA03	Tropisetron	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AA04	Dolasetron	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AA05	Palonosetron	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AD	Andere Antiemetika	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AD01	Scopolamin	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AD02	Ceriumoxalat	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AD04	Chlorbutanol	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AD05	Metopimazin	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AD10	Dronabinol	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AD11	Nabilon	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AD12	Aprepitant	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AD51	Scopolamin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AD54	Chlorbutanol, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A05	Gallen- und Lebertherapie	WHO Anatomical Therapeutic Chemical classification
0‑L	A05A	Gallentherapie	WHO Anatomical Therapeutic Chemical classification
0‑L	A05AA	Gallensäure-haltige Zubereitungen	WHO Anatomical Therapeutic Chemical classification
0‑L	A05AA01	Chenodeoxycholsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	A05AA02	Ursodeoxycholsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	A05AB	Zubereitungen zur Gallentherapie	WHO Anatomical Therapeutic Chemical classification
0‑L	A05AB01	N-(Hydroxymethyl)nicotinamid	WHO Anatomical Therapeutic Chemical classification
0‑L	A05AX	Andere Mittel zur Gallentherapie	WHO Anatomical Therapeutic Chemical classification
0‑L	A05AX01	Piprozolin	WHO Anatomical Therapeutic Chemical classification
0‑L	A05AX02	Hymecromon	WHO Anatomical Therapeutic Chemical classification
0‑L	A05AX03	Cyclobutyrol	WHO Anatomical Therapeutic Chemical classification
0‑L	A05B	Lebertherapie, Lipotrope Substanzen	WHO Anatomical Therapeutic Chemical classification
0‑L	A05BA	Lebertherapie	WHO Anatomical Therapeutic Chemical classification
0‑L	A05BA01	Argininglutamat	WHO Anatomical Therapeutic Chemical classification
0‑L	A05BA03	Silymarin	WHO Anatomical Therapeutic Chemical classification
0‑L	A05BA04	Citiolon	WHO Anatomical Therapeutic Chemical classification
0‑L	A05BA05	Epomediol	WHO Anatomical Therapeutic Chemical classification
0‑L	A05BA06	Ornithinoxoglurat	WHO Anatomical Therapeutic Chemical classification
0‑L	A05BA07	Tidiacicarginin	WHO Anatomical Therapeutic Chemical classification
0‑L	A05C	Mittel zur Gallentherapie und Lipotrope Substanzen in Kombination	WHO Anatomical Therapeutic Chemical classification
0‑L	A06	Laxanzien	WHO Anatomical Therapeutic Chemical classification
0‑L	A06A	Laxanzien	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AA	Gleitmittel, Emollientia	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AA01	Dickflüssiges Paraffin	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AA02	Docusat-Natrium	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AA51	Dickflüssiges Paraffin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB	Kontaktlaxanzien	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB01	Oxyphenisatin	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB02	Bisacodyl	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB03	Dantron	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB04	Phenolphthalein	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB05	Rizinusöl	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB06	Sennoside	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB07	Cascara	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB08	Natriumpicosulfat	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB09	Bisoxatin	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB20	Kontaktlaxanzien in Kombination	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB30	Kontaktlaxanzien in Kombination mit Belladonna-Alkaloiden	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB52	Bisacodyl, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB53	Dantron, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB56	Sennoside, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB57	Cascara, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB58	Natriumpicosulfat, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AC	Quellmittel	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AC01	Ispaghula (Flohsamen)	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AC02	Ethulose	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AC03	Sterculia	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AC05	Leinsamen	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AC06	Methylcellulose	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AC07	Triticum (Weizenkleie)	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AC08	Polycarbophil-Calcium	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AC51	Ispaghula, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AC53	Sterculia, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AC55	Leinsamen, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD	Osmotisch wirkende Laxanzien	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD01	Magnesiumcarbonat	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD02	Magnesiumoxid	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD03	Magnesiumperoxid	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD04	Magnesiumsulfat	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD10	Mineralsalze in Kombination	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD11	Lactulose	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD12	Lactitol	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD13	Natriumsulfat	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD14	Pentaerythrityl	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD15	Macrogol	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD16	Mannitol	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD17	Natriumphosphat	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD18	Sorbitol	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD19	Magnesiumcitrat	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD21	Natriumtartrat	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD61	Lactulose, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD65	Macrogol, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AG	Klysmen	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AG01	Natriumphosphat	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AG02	Bisacodyl	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AG03	Dantron, inkl. Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AG04	Glycerol	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AG06	Öl	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AG07	Sorbitol	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AG10	Docusat-Natrium, inkl. Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AG11	Laurylsulfat, inkl. Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AG20	Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AH01	Methylnaltrexon bromid	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AX	Andere Laxanzien	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AX01	Glycerol	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AX02	Kohlendioxid-freisetzende Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	A07	Antidiarrhoika und intestinale Antiphlogistika/Antiinfektiva	WHO Anatomical Therapeutic Chemical classification
0‑L	A07A	Intestinale Antiinfektiva	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AA	Antibiotika	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AA01	Neomycin	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AA02	Nystatin	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AA03	Natamycin	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AA04	Streptomycin	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AA05	Polymyxin B	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AA06	Paromomycin	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AA07	Amphotericin B	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AA08	Kanamycin	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AA09	Vancomycin	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AA10	Colistin	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AA11	Rifaximin	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AA12	Fidaxomicin	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AA51	Neomycin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AA54	Streptomycin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AB	Sulfonamide	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AB02	Phthalylsulfathiazol	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AB03	Sulfaguanidin	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AB04	Succinylsulfathiazol	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AC	Imidazol-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AC01	Miconazol	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AX	Andere intestinale Antiinfektiva	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AX01	Broxychinolin	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AX02	Acetarsol	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AX03	Nifuroxazid	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AX04	Nifurzid	WHO Anatomical Therapeutic Chemical classification
0‑L	A07B	Intestinale Adsorbenzien	WHO Anatomical Therapeutic Chemical classification
0‑L	A07BA	Kohle-haltige Zubereitungen	WHO Anatomical Therapeutic Chemical classification
0‑L	A07BA01	Medizinische Kohle	WHO Anatomical Therapeutic Chemical classification
0‑L	A07BA51	Medizinische Kohle, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A07BB	Bismut-haltige Zubereitungen	WHO Anatomical Therapeutic Chemical classification
0‑L	A07BC	Andere intestinale Adsorbenzien	WHO Anatomical Therapeutic Chemical classification
0‑L	A07BC01	Pektin	WHO Anatomical Therapeutic Chemical classification
0‑L	A07BC02	Kaolin	WHO Anatomical Therapeutic Chemical classification
0‑L	A07BC03	Crospovidon	WHO Anatomical Therapeutic Chemical classification
0‑L	A07BC04	Attapulgit	WHO Anatomical Therapeutic Chemical classification
0‑L	A07BC05	Diosmectit	WHO Anatomical Therapeutic Chemical classification
0‑L	A07BC30	Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A07BC54	Attapulgit, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A07C	Elektrolyte mit Kohlenhydraten	WHO Anatomical Therapeutic Chemical classification
0‑L	A07CA	Elektrolyte zur oralen Rehydrierung	WHO Anatomical Therapeutic Chemical classification
0‑L	A07D	Motilitätshemmer	WHO Anatomical Therapeutic Chemical classification
0‑L	A07DA	Motilitätshemmer	WHO Anatomical Therapeutic Chemical classification
0‑L	A07DA01	Diphenoxylat	WHO Anatomical Therapeutic Chemical classification
0‑L	A07DA02	Opium	WHO Anatomical Therapeutic Chemical classification
0‑L	A07DA03	Loperamid	WHO Anatomical Therapeutic Chemical classification
0‑L	A07DA04	Difenoxin	WHO Anatomical Therapeutic Chemical classification
0‑L	A07DA05	Loperamidoxid	WHO Anatomical Therapeutic Chemical classification
0‑L	A07DA52	Morphin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A07DA53	Loperamid, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A07E	Intestinale Antiphlogistika	WHO Anatomical Therapeutic Chemical classification
0‑L	A07EA	Corticosteroide mit lokaler Wirkung	WHO Anatomical Therapeutic Chemical classification
0‑L	A07EA01	Prednisolon	WHO Anatomical Therapeutic Chemical classification
0‑L	A07EA02	Hydrocortison	WHO Anatomical Therapeutic Chemical classification
0‑L	A07EA03	Prednison	WHO Anatomical Therapeutic Chemical classification
0‑L	A07EA04	Betamethason	WHO Anatomical Therapeutic Chemical classification
0‑L	A07EA05	Tixocortol	WHO Anatomical Therapeutic Chemical classification
0‑L	A07EA06	Budesonid	WHO Anatomical Therapeutic Chemical classification
0‑L	A07EA07	Beclometason	WHO Anatomical Therapeutic Chemical classification
0‑L	A07EB	Antiallergika, exkl. Corticosteroide	WHO Anatomical Therapeutic Chemical classification
0‑L	A07EB01	Cromoglicinsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	A07EC	Aminosalicylsäure und ähnliche Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	A07EC01	Sulfasalazin	WHO Anatomical Therapeutic Chemical classification
0‑L	A07EC02	Mesalazin	WHO Anatomical Therapeutic Chemical classification
0‑L	A07EC03	Olsalazin	WHO Anatomical Therapeutic Chemical classification
0‑L	A07EC04	Balsalazid	WHO Anatomical Therapeutic Chemical classification
0‑L	A07F	Mikrobielle Antidiarrhoika	WHO Anatomical Therapeutic Chemical classification
0‑L	A07FA	Mikrobielle Antidiarrhoika	WHO Anatomical Therapeutic Chemical classification
0‑L	A07FA01	Milchsäurebildner	WHO Anatomical Therapeutic Chemical classification
0‑L	A07FA02	Saccharomyces boulardii	WHO Anatomical Therapeutic Chemical classification
0‑L	A07FA51	Milchsäurebildner, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A07X	Andere Antidiarrhoika	WHO Anatomical Therapeutic Chemical classification
0‑L	A07XA	Andere Antidiarrhoika	WHO Anatomical Therapeutic Chemical classification
0‑L	A07XA01	Albumintannat	WHO Anatomical Therapeutic Chemical classification
0‑L	A07XA02	Ceratonia	WHO Anatomical Therapeutic Chemical classification
0‑L	A07XA03	Calcium-haltige Verbindungen	WHO Anatomical Therapeutic Chemical classification
0‑L	A07XA04	Racecadotril	WHO Anatomical Therapeutic Chemical classification
0‑L	A07XA51	Albumintannat, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A08	Abmagerungsmittel, Exkl. Diätetika	WHO Anatomical Therapeutic Chemical classification
0‑L	A08A	Abmagerungsmittel, Exkl. Diätetika	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AA	Zentral wirkende Abmagerungsmittel	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AA01	Phentermin	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AA02	Fenfluramin	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AA03	Amfepramon	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AA04	Dexfenfluramin	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AA05	Mazindol	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AA06	Etilamfetamin	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AA07	Cathin	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AA08	Clobenzorex	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AA09	Mefenorex	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AA10	Sibutramin	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AA56	Ephedrin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AB	Peripher wirkende Abmagerungsmittel	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AB01	Orlistat	WHO Anatomical Therapeutic Chemical classification
0‑L	A09	Digestiva, Inkl. Enzyme	WHO Anatomical Therapeutic Chemical classification
0‑L	A09A	Digestiva, Inkl. Enzyme	WHO Anatomical Therapeutic Chemical classification
0‑L	A09AA	Enzym-haltige Zubereitungen	WHO Anatomical Therapeutic Chemical classification
0‑L	A09AA01	Diastase	WHO Anatomical Therapeutic Chemical classification
0‑L	A09AA02	Multienzyme (Lipase, Protease etc.)	WHO Anatomical Therapeutic Chemical classification
0‑L	A09AA03	Pepsin	WHO Anatomical Therapeutic Chemical classification
0‑L	A09AA04	Tilactase	WHO Anatomical Therapeutic Chemical classification
0‑L	A09AB	Säure-haltige Zubereitungen	WHO Anatomical Therapeutic Chemical classification
0‑L	A09AB01	Glutaminsäurehydrochlorid	WHO Anatomical Therapeutic Chemical classification
0‑L	A09AB02	Betainhydrochlorid	WHO Anatomical Therapeutic Chemical classification
0‑L	A09AB03	Salzsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	A09AB04	Zitronensäure	WHO Anatomical Therapeutic Chemical classification
0‑L	A09AC	Enzym- und Säure-haltige Zubereitungen, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A09AC01	Pepsin- und Säure-haltige Zubereitungen	WHO Anatomical Therapeutic Chemical classification
0‑L	A09AC02	Multienzyme und säure-haltige Zubereitungen	WHO Anatomical Therapeutic Chemical classification
0‑L	A10	Antidiabetika	WHO Anatomical Therapeutic Chemical classification
0‑L	A10A	Insuline Und Analoga	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AA	Insulins	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AB	Insuline und Analoga zur Injektion, schnell wirkend	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AB01	Insulin (human)	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AB02	Insulin (Rind)	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AB03	Insulin (Schwein)	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AB04	Insulin lispro	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AB05	Insulin aspart	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AB06	Insulin glulisin	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AB30	Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AC	Insuline und Analoga zur Injektion, intermediär wirkend	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AC01	Insulin (human)	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AC02	Insulin (Rind)	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AC03	Insulin (Schwein)	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AC04	Insulin lispro	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AC30	Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AD	Insuline und Analoga zur Injektion, intermediär wirkend kombiniert mit schnell wirkend	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AD01	Insulin (human)	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AD02	Insulin (Rind)	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AD03	Insulin (Schwein)	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AD04	Insulin lispro	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AD05	Insulin aspart	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AD30	Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AE	Insuline und Analoga zur Injektion, lang wirkend	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AE01	Insulin (human)	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AE02	Insulin (Rind)	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AE03	Insulin (Schwein)	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AE04	Insulin glargin	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AE05	Insulin detemir	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AE30	Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AF	Insuline und Analoga zur Inhalation	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AF01	Insulin (human)	WHO Anatomical Therapeutic Chemical classification
0‑L	A10B	Antidiabetika, Exkl. Insuline	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BA	Biguanide	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BA01	Phenformin	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BA02	Metformin	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BA03	Buformin	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BB	Sulfonylharnstoff-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BB01	Glibenclamid	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BB02	Chlorpropamid	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BB03	Tolbutamid	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BB04	Glibornurid	WHO Anatomical Therapeutic Chemical classification
Dieses Value Set beinhaltet 6063 Codes. Um die Publikationsgröße überschaubar zu halten, wird nur eine Auswahl (500 Codes) des ganzen Sets von Codes gezeigt.

Legende: Typ L=leaf, S=specializable, A=abstract, D=deprecated. NullFlavor OTH (other) schlägt Text in originalText vor. HL7 V3: NullFlavors werden im @nullFlavor Attribut statt in @code angegeben.

XML JSON CSV SQL SVS